Patents by Inventor Georges Wagnieres

Georges Wagnieres has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230364442
    Abstract: The invention relates to a device for applying Photobiomodulation (PBM) on a biological object comprising a light source delivering light with an adequate temporal evolution of its optical power, said device also comprising a processing and/or a light control unit that determines the adequate temporal evolution of the optical power on the basis of the biological object optical coefficients and the light delivery geometry on/in the biological object, characterized by the fact that the PBM effects are induced by the generation of one or several specific fluence rates during one or several specific times, successively, in each parts of the volume of the biological object. said specific combined fluence rate(s) and said times being selected in the following groups of parameters : 3±2 mW/cm2 during 180±30 s or 11±9 mW/cm2 during 80±25 s or 16±10 mW/cm2 during 40±20 s or 25±10 mW/cm2 during 15±10 s or 10±9.7 mW/cm2 during 40±1 s.
    Type: Application
    Filed: October 1, 2021
    Publication date: November 16, 2023
    Inventors: Emmanuel GERELLI, Jaroslava JONIOVA, Sébastien GERELLI, Georges WAGNIÈRES, Michel BONNEAU
  • Publication number: 20230172501
    Abstract: The disclosure relates to methods and devices for monitoring the concentration of a substance, preferably oxygen, in a cell or tissue, e.g., in cells of the human skin. In particular, it provides a method for determining the concentration of a quencher, such as oxygen and/or the concentration of a probe, e.g., a heme precursor such as protoporphyrin IX (PpIX), wherein the probe is capable of exhibiting luminescence (delayed fluorescence (DF) or phosphorescence) and or transient triplet absorption, preferably, deDF, in a living cell. The method comprises steps of exciting the probe, measuring the lifetime of the luminescence exhibited by said probe, herein, in the presence of the quencher, the lifetime is shortened as compared to the lifetime in the absence of the quencher, and correlating said lifetime with said concentration.
    Type: Application
    Filed: May 21, 2021
    Publication date: June 8, 2023
    Inventors: Gauthier CROIZAT, Egbert G. MIK, Georges WAGNIÉRES, Emmanuel GERELLI
  • Patent number: 8492578
    Abstract: The present invention relates to photosensitizer compounds for use in cosmetic and therapeutic applications of photodynamic therapy. The compounds of the present invention are designed for topical application and are characterized by a low permeability to the stratum corneum (the outer skin layer of an individual) and/or a low allergenic potential. Surprisingly, such compounds have beneficial properties in the treatment of certain diseases and lack the undesired damages to healthy skin entailed by prior art compounds. ALA (5-aminolevulinic acid)-esters of body-owned, natural compound such as aminoacids, steroids, carbohydrates, alcohols are preferred examples of photosensitizers of the present invention. The compounds of the present invention are used in the treatment of skin diseases such as psoriasis, sebaceous glands related conditions including acne, seborrhoic dermatitis, rosacea, skin cancer and precancer, as well as in cosmetic hair removal.
    Type: Grant
    Filed: December 12, 2008
    Date of Patent: July 23, 2013
    Assignee: Photoderma SA
    Inventors: Thomas Glanzmann, Jérôme Barge, Georges Wagnieres
  • Patent number: 8235974
    Abstract: A method for hair removal from a skin area by selective photo-inactivation of the pilo-sebaceous apparatus using derivatives of ALA with alkylene-glycol chains. Selectivity of the method is further enhanced by treatment of the epidermis by agents reducing PpIX levels in the epidermis. Side effects are diminished by using short drug/light intervals.
    Type: Grant
    Filed: November 15, 2002
    Date of Patent: August 7, 2012
    Assignee: Ecole Polytechnique Federale de Lausanne (EPFL)
    Inventors: Georges Wagnieres, Norbert Lange, Nora Dögnitz, Denis Salomon, Hubert Van Den Bergh
  • Patent number: 8019405
    Abstract: A device for picture-providing diagnosis of tissue is selectively operated in a picture-providing white light diagnosis mode and a picture providing auto-fluorescence mode. A color camera having red, green, and blue sensors provides a monitor which picture signals. A light source emits fluorescence excitation light and additionally emits so much red light that the red light remitted by the tissue dominates the red fluorescence light in the picture providing auto-fluorescence mode. The signal from the red sensor of the camera is damped so that normal time appears green and pre-malignant and early malignant tissue appears red.
    Type: Grant
    Filed: April 4, 2002
    Date of Patent: September 13, 2011
    Assignee: Richard Wolf GmbH
    Inventors: Bernd Claus Weber, Thomas Goll, Olaf Schmidt, Philipp Eidner, Stefan Müller, Hubert van den Bergh, Didier Goujon, Georges Wagnières
  • Publication number: 20100273725
    Abstract: The present invention relates to photosensitizer compounds for use in cosmetic and therapeutic applications of photodynamic therapy. The compounds of the present invention are designed for topical application and are characterized by a low permeability to the stratum corneum (the outer skin layer of an individual) and/or a low allergenic potential. Surprisingly, such compounds have beneficial properties in the treatment of certain diseases and lack the undesired damages to healthy skin entailed by prior art compounds. ALA (5-aminolevulinic acid)-esters of body-owned, natural compound such as aminoacids, steroids, carbohydrades, alcohols are preferred, examples of photosensitizers of the present invention. The compounds of the present invention are used in the treatment of skin diseases such as psoriasis, sebaceous glands related conditions including acne, seborrhoic dermatitis, rosacea, skin cancer and precancer, as well as in cosmetic hair removal.
    Type: Application
    Filed: December 12, 2008
    Publication date: October 28, 2010
    Inventors: Thomas Glanzmann, Jérôme Barge, Georges Wagnieres
  • Patent number: 7348361
    Abstract: The invention concerns a 5-aminolevulinic acid ester (E-ALA) solution for producing a pharmaceutical preparation useful for diagnosing and/or treating tissue and/or cell pathologies by local radiation exposure using radiation emitted by a light source energy followed, in the case diagnosis, by detection of fluorescent protoporphyrin IX (Pp1X). The E-ALA concentration in the solution is less than 1% and ranges between 0.01% and 0.5%. The low E-ALA concentration in the solution increases Pp1X synthesis and homogenises its distribution in the cell layers while highly reducing the secondary toxicity for the treated cells.
    Type: Grant
    Filed: April 22, 1999
    Date of Patent: March 25, 2008
    Assignee: Ecole Polytechnique Federale de Lausanne
    Inventors: Alexandre Marti, Norbert Lange, Matthieu Zellweger, Georges Wagnieres, Hubert Van Den Bergh, Patrice Jichlinski, Pavel Kucera
  • Publication number: 20050124984
    Abstract: A method for hair removal from a skin area by selective photo-inactivation of the pilo-sebaceous apparatus using derivatives of ALA with alkylene-glycol chains. Selectivity of the method is further enhanced by treatment of the epidermis by agents reducing PpIX levels in the epidermis. Side effects are diminished by using short drug/light intervals.
    Type: Application
    Filed: November 15, 2002
    Publication date: June 9, 2005
    Inventors: Georges Wagnieres, Norbert Lange, Nora Dognitz, Denis Salomon, Hubert Van Den Bergh
  • Publication number: 20030158258
    Abstract: The invention concerns a 5-aminolevulinic acid ester (E-ALA) solution for producing a pharmaceutical preparation useful for diagnosing and/or treating tissue and/or cell pathologies by local radiation exposure using radiation emitted by a light source energy followed, in the case diagnosis, by detection of fluorescent protoporphyrin IX (Pp1X). The E-ALA concentration in the solution is less than 1% and ranges between 0.01% and 0.5%. The low E-ALA concentration in the solution increases Pp1X synthesis and homogenises its distribution in the cell layers while highly reducing the secondary toxicity for the treated cells.
    Type: Application
    Filed: October 20, 2000
    Publication date: August 21, 2003
    Inventors: Alexandre Marti, Norbert Lange, Mattieu Zellweger, Georges Wagnieres, Hubert Van Dew Bergh, Patrice Jichlinski, Pavel Kucera
  • Publication number: 20020147383
    Abstract: There is described a device for the picture-providing diagnosis of tissue with the selective application of two diagnosis methods, specifically an operating mode for the picture-providing white light diagnosis and an operating mode for the picture-providing auto-flourescence. The device has a light source whose light is led to the tissue via an endoscope, wherein in the endoscope there is arranged a picture transmission unit which leads the picture of the tissue to a color camera. The color camera comprises three sensors allocated to the color regions red, green and blue which are in connection with a picture processor unit which provides a monitor with the picture signals.
    Type: Application
    Filed: April 4, 2002
    Publication date: October 10, 2002
    Applicant: Richard Wolf GmbH
    Inventors: Bernd Claus Weber, Thomas Goll, Olaf Schmidt, Philipp Eidner, Stefan Muller, Hubert van den Bergh, Didier Goujon, Georges Wagnieres
  • Patent number: 6364874
    Abstract: A device for the irradiation of internal cavities of the body includes a flexible catheter, made of a transparent material, containing a fiber optic of which the section at one end is designed to radially diffuse light coming from a source arranged at the other end. An inflatable balloon fixed to one end of the catheter surrounds the diffusing section of the fiber optic. The balloon is made of an elastomeric material that diffuses the light and is prefabricated by molding based on the shape of the cavity to be treated. The balloon presses against the cavity wall and, with the thickness of its surfaces remaining constant after inflation, the pressure needed for inflation is low and cannot damage the cavity tissues.
    Type: Grant
    Filed: April 30, 1999
    Date of Patent: April 2, 2002
    Assignee: Medlight S.A.
    Inventors: Roland Bays, Alain Woodtli, Georges Wagnieres, Hubert Van Den Bergh
  • Patent number: 6148227
    Abstract: The diagnosis apparatus according to the invention for the picture providing recording of fluorescing biological tissue by way of an endoscope contains a stimulation light source which beams spectral components suitable for fluorescence stimulation into the tissue through the endoscope. The fluorescent light reflected by the tissue reaches through the endoscope optics into a head piece where it is split into a green, and spacially separated from this, a red spectral component and falls each on one half of a CCD solid body of a highly sensitive black and white camera.
    Type: Grant
    Filed: June 16, 1998
    Date of Patent: November 14, 2000
    Assignee: Richard Wolf GmbH
    Inventors: Georges Wagnieres, Matthieu Zellweger, Nicolas Chauvin, Norbert Lange, Ulf Zanger, Andre Studzinski, Hubert van den Bergh
  • Patent number: 5219346
    Abstract: A light diffuser for simultaneous photodynamic therapy and hyperthermic treatment in the oesophagus has an arrangement (14 to 18) which disperses radially the light (10) fed in by way of an optical fiber (6) and has a tube (12) filled with silicone to which are added concentrations, modulated in the axial direction, of quartz grains having a diameter of approximately 40 .mu.m which bring about a refraction having little dependence on the wavelength.
    Type: Grant
    Filed: January 4, 1991
    Date of Patent: June 15, 1993
    Assignee: Ciba-Geigy Corporation
    Inventors: Georges Wagnieres, Hubert van den Bergh, Philippe Monnier
  • Patent number: 5146917
    Abstract: A bronchoscope has a fibre-optic apparatus for the photodynamic treatment of tumors in the region of the furcate branches of the bronchi, the divergent pencil of rays (13), which emerges from the end face (9) of an optical fibre, striking a lens arrangement consisting of two microlenses (14,15) which, owing to the spherical aberration, deflect edge rays (23) in the divergent pencil of rays (13) of the optical fibre (8) in such a manner that a homogeneous sharp-edged emerging pencil of rays is formed.
    Type: Grant
    Filed: January 4, 1991
    Date of Patent: September 15, 1992
    Assignee: Ciba-Geigy Corporation
    Inventors: Georges Wagnieres, Hubert van den Bergh, Philippe Monnier
  • Patent number: 5117474
    Abstract: In a device for injecting the light energy of a laser beam into a multimode fibre-optic optical waveguide (2) a small part of the light emerging from the end face of the optical waveguide (2) is projected through a beam splitting cube (7) and a reproducing lens (21) onto a display screen (1), so that an image (24) of the end face of the optical waveguide (2) can be observed on the display screen (1). The arrangement is such that the system is correctly focused only when the distance between the optical waveguide (2) and a focusing point of the laser beam (12) reaches an intended value. The light spot of the laser beam on the end face of the optical waveguide (2) is clearly visible on the display screen (1) so than an optimum positioning and adjustment can be readily effected.
    Type: Grant
    Filed: October 2, 1990
    Date of Patent: May 26, 1992
    Assignee: Ciba-Geigy Corporation
    Inventors: Hubert van den Bergh, Peter F. Cornaz, deceased, Max M. Cornaz, heir, Jean-Pierre Cornaz, heir, Maria I. Cornaz, heir, Georges Wagnieres
  • Patent number: 5068515
    Abstract: An apparatus for precise, homogeneous and sharp-edged irradiation of a large area with the light of a laser beam (5), which can be used especially for large-area photodynamic therapy, is provided with a multimode fibre (10), which is illuminated by the laser beam by way of a microscope objective (4) and has a length of approximately 5 meters, and the end face (13) of which is imaged onto an irradiated area (7) of a working surface (6) by means of a microscope (17).
    Type: Grant
    Filed: December 19, 1990
    Date of Patent: November 26, 1991
    Assignee: Ciba-Geigy Corporation
    Inventors: Hubert van den Bergh, Peter F. Cornaz, deceased, Max M. Cornaz, heir, Jean-Pierre Cornaz, heir, Maria I. Cornaz, heir, Georges Wagnieres
  • Patent number: 5054867
    Abstract: An apparatus for irradiating the bronchi of a patient for the purpose of photodynamic therapy has an optical fibre (11) that feeds the light of a laser into a bronchoscope and is surrounded by a light-guide tube (8) and an outer tube (2). The distal end (13) of the optical fibre (11) is embedded in a silicone composition (17) containing 7 parts per thousand of TiO.sub.2 particles having a particle size of 0.2 .mu.m. The silicone composition (17) fills the front end of the light-guide tube (8) as far as the end face (6) of an aluminium cylinder (5) which acts as a mirror. The light dispersed by the TiO.sub.2 particles is emitted radially through the light-guide tube (8) and the front portion of the outer tube (2) and acts on the patient's bronchi.
    Type: Grant
    Filed: January 4, 1991
    Date of Patent: October 8, 1991
    Assignee: Ciba-Geigy Corporation
    Inventors: Georges Wagnieres, Hubert van den Bergh, Philippe Monnier
  • Patent number: 4998797
    Abstract: An optical waveguide plug connection for the transmission of high continuous wave light powers from an incoming optical waveguide into an outgoing optical waveguide comprises a metallic plug housing equipped with a metallic centering element. The incoming optical waveguide and the outgoing optical waveguide project into the centering element, the end faces of the two optical waveguides being arranged opposite each other. The width of the gap is approximately in the range of from 5 to 30 micrometres. The core diameter of the outgoing optical waveguide is approximately one third larger than the core diameter of the incoming optical waveguide. The gap is filled with gas. The plug housing is connected to a housing of large surface area which dissipates heat. Using this plug connection, continuous wave powers of up to some 100's of watts in the case of visible to infrared laser light can be transmitted with a high degree of coupling without danger to the end faces of the coupling connection.
    Type: Grant
    Filed: August 7, 1990
    Date of Patent: March 12, 1991
    Assignee: Ciba-Geigy Corporation
    Inventors: Hubert van den Bergh, Georges Wagnieres